Gilpin Wealth Management’s Genmab GMAB Stock Holding History

Gilpin Wealth Management’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$3.92K	Buy	+110	New	+$3.48K	﹤0.01%	474

Other funds holding GMAB

Legacy Wealth Asset Management Woodbury, Minnesota $456M AUM 31.62% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

Marotta Asset Management Charlottesville, Virginia $589M AUM 14.57% 1-Year Est. Return

Juncture Wealth Strategies Scottsdale, Arizona $390M AUM 19.15% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Elevation Wealth Partners Santa Rosa, California $356M AUM 17.04% 1-Year Est. Return

Miller Global Investments Dallas, Texas $124M AUM 25.7% 1-Year Est. Return

Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return

Retirement Wealth Solutions Marshfield, Wisconsin $189M AUM 13.41% 1-Year Est. Return

Gilpin Wealth Management's GMAB Position: Q3 2026 in Review

Gilpin Wealth Management opened a new position in Genmab (GMAB) in Q3 2026: 110 shares worth $3.92K. The stake represents ﹤0.01% of the portfolio and ranks #474 among its holdings.

13 funds tracked by Wall St. Rank hold GMAB as of Q3 2026.

Gilpin Wealth Management held 110 shares of Genmab worth $3.92K as of Q3 2026.
Genmab was a new Gilpin Wealth Management position in Q3 2026.
Genmab made up ﹤0.01% of Gilpin Wealth Management's portfolio in Q3 2026, its #474 holding.
13 funds tracked by Wall St. Rank held Genmab as of Q3 2026.

Based on Gilpin Wealth Management's 13F filing for Q3 2026, filed 9 Oct 2026.